Stay updated on Daratumumab Combo in Resistant Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Combo in Resistant Myeloma Clinical Trial page.

Latest updates to the Daratumumab Combo in Resistant Myeloma Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.5.4 was added, replacing the previous v3.5.3; this indicates an update to the page's underlying software/version label rather than a change to the study content.SummaryDifference0.0%

- Check11 days agoChange DetectedThe disease keyword 'Multiple myeloma' and the related topics section including MedlinePlus Genetics have been removed. This changes how the study is categorized on the page and eliminates a direct link to related resources.SummaryDifference0.1%

- Check18 days agoChange DetectedRevision tag updated from v3.5.2 to v3.5.3, indicating a small backend/template update for the page. The study details themselves remain unchanged.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedSite revision updated to v3.5.2; removed the 'Multiple myeloma' topic and the 'MedlinePlus Genetics' related topics, and the previous 'Revision: v3.5.0' note.SummaryDifference0.2%

- Check39 days agoChange DetectedAdded a Publications section containing the final results of IFM2014-04 (Daratumumab + Dexamethasone) with DOI 10.1111/bjh.16059 and related note; updated Study Results with the 2026-04-01 entry.SummaryDifference0.3%

- Check47 days agoChange Detected- Added 'Multiple myeloma' as a related topic and linked a related topic to MedlinePlus Genetics. This expands disease context and provides quick access to background genetics information.SummaryDifference0.1%

Stay in the know with updates to Daratumumab Combo in Resistant Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo in Resistant Myeloma Clinical Trial page.